Stay updated with breaking news from Bowel Project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer. First PARP inhibitor to...
Press release content from Business Wire. The AP news staff was not involved in its creation.
First PARP inhibitor to demonstrate overall survival benefit in early breast cancer ... | March 16, 2022
Based on the results of their new study, City of Hope researchers advised doctors against overreliance on Natera's Signatera assays for recurrence monitoring.
Based on the results of their new study, City of Hope researchers advised doctors against overreliance on Natera's Signatera assays for recurrence monitoring.